Head-to-head · Cost-Efficiency Index
Tell Her Doc vs WeightRx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Tell Her Doc
Cost-first shoppers who want women seeking a well-documented, LegitScript-verified provider -- but get the real recurring price before trusting the $269 headline.
Visit Tell Her DocWeightRx
Cost-first shoppers who want the lowest published tirzepatide figure, if you are willing to complete intake before you can read the plan terms.
Visit WeightRxThe verdict
Tell Her Doc and WeightRx tie on the Cost-Efficiency Index at 69/100, so neither wins outright on the numbers. For most shoppers we'd start with Tell Her Doc (ranked #108, a hair above #109) — Cost-first shoppers who want women seeking a well-documented, LegitScript-verified provider -- but get the real recurring price before trusting the $269 headline. But WeightRx is a genuine coin-flip alternative here.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the ranking). See how it stacks up: CoreAge Rx vs Tell Her Doc.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Tell Her Doc | WeightRx |
|---|---|---|
| Cost-Efficiency Index | 69/100 | 69/100 |
| Semaglutide / mo | $269/mo (compounded oral) | $250/mo (compounded) |
| Tirzepatide / mo | Not disclosed | $83/mo (term not published, compounded) |
| Semaglutide / yr (modeled) | $3,228 | $3,000 |
| Tirzepatide / yr (modeled) | — | $996 |
| Coverage | All 50 states | Coverage not published |
| Oral / sublingual | Yes | No |
| Brand-name access | Yes | Compounded only |
| Rank here | #108 | #109 |
Tell Her Doc
69/100Where the value is
- Four named, NPI-verified physicians -- unusually transparent medical leadership for this category
- Four named compounding pharmacy partners (Belmar, Strive, Epiq Scripts, Casa Pharma Rx)
- Claims and displays coverage across all 50 states
The tradeoffs
- Headline '$269 / $140 off' price is a prepaid, first-time-customer, oral-semaglutide-only promo -- not a general or recurring rate
- No standalone tirzepatide price disclosed
WeightRx
69/100Where the value is
- The tirzepatide figure is published up front, and it is genuinely low against the field
- Both molecules are offered
- No membership charge is advertised alongside the medication rate
The tradeoffs
- The $83 monthly rate is advertised as '$83/month ($997/year)', which is twelve months of it — no month-to-month rate is separately published, and the terms state that a rate is locked for its full term
- Both product pages linked from the homepage return 404, so the plan terms cannot be read before intake
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.